# Additive Formula 3

NDC: 14537-832
Generic name: Dextrose Monohydrate, TRISODIUM CITRATE DIHYDRATE, Sodium Chloride, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, Citric Acid Monohydrate, and Adenine
Labeler / Manufacturer: Terumo BCT, Ltd
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION
Routes: INTRAVENOUS
Marketing started: 20020529

FDA application: BN001214

## Active ingredients

- ADENINE: .03 g/100mL
- CITRIC ACID MONOHYDRATE: .042 g/100mL
- DEXTROSE MONOHYDRATE: 1.1 g/100mL
- SODIUM CHLORIDE: .41 g/100mL
- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE: .28 g/100mL
- TRISODIUM CITRATE DIHYDRATE: .59 g/100mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"14537-832"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=14537-832
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9a5247a1-cc05-442d-b2d0-950f887f03c2